TTC21A, also known as tetratricopeptide repeat domain 21A, is a protein that has not been as extensively characterized as some other proteins. However, based on its name and the presence of the tetratricopeptide repeat (TPR) domain, it can be inferred that it likely plays a role in protein-protein interactions and may be involved in the assembly of multiprotein complexes.The TPR motif is a structural motif present in a variety of proteins and is known to facilitate protein-protein interactions. It consists of a series of tandem repeats of 34 amino acids that form a helix-turn-helix structure. This structure often acts as a scaffold for the formation of protein complexes, which are essential for various cellular processes, such as signal transduction, protein folding, and transport.
Proteins containing TPR domains are involved in a wide range of functions. For example, they can mediate the interaction between chaperone proteins such as Hsp70/Hsp90 and their co-chaperones, which are crucial for protein folding and stabilization. TPR domain proteins are also found in the mitochondrial import machinery, where they recognize mitochondrial targeting sequences and facilitate the import of proteins into the mitochondria. Research into TTC21A and other less-characterized proteins is important for expanding our understanding of cellular function and may lead to the identification of novel pathways.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, could affect TTC21A by altering MAPK/ERK pathway signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially influencing TTC21A activity by modulating stress-activated protein kinase pathways. | ||||||